&nbsp;

Oct 2025

Drug

ixazomib

Other Name(s): Ninlaro™

Quick Link(s):

Jun 2019

Drug

venetoclax

Other Name(s): Venclexta®

Quick Link(s):

Aug 2025

Drug

atezolizumab

Other Name(s): Tecentriq™

Quick Link(s):

Jul 2025

Drug

midostaurin

Other Name(s): Rydapt®

Quick Link(s):

Jun 2025

Regimen

ALDE(Intralesional)

Cancer Type:

Skin,

Melanoma

Intent: Palliative, Curative

Funding:

New Drug Funding Program

Aldesleukin (interleukin-2) - In-Transit Metastases from Melanoma

Drugs Used:

aldesleukin

Quick Link(s):

Regimen Monograph

May 2019

Regimen

ALEM; ALEM(IV)

Cancer Type:

Hematologic,

Leukemia - Chronic Lymphocytic (CLL)

Intent: Palliative

Drugs Used:

alemtuzumab (Compassionate)

Quick Link(s):

Regimen Monograph

Nov 2019

Regimen

DASA

Cancer Type:

Hematologic,

Leukemia - Chronic Myeloid (CML)

Intent: Palliative

Funding:

Exceptional Access Program

daSAtinib - Ph+ CML in the chronic phase, with specific criteria

Exceptional Access Program

daSAtinib - Accelerated phase or blast phase Ph+ CML with documented resistance or intolerance to imatinib, with specific criteria

Drugs Used:

daSATinib

Quick Link(s):

Regimen Monograph

Feb 2025

Regimen

DCRB

Cancer Type:

Sarcoma,

Soft Tissue,

Skin,

Melanoma

Intent: Palliative

Drugs Used:

dacarbazine

Quick Link(s):

Regimen Monograph

Jun 2025

Regimen

DEXA(PO)

Cancer Type:

Hematologic,

Multiple Myeloma

Intent: Palliative

Funding:

ODB - General Benefit

dexamethasone

Drugs Used:

dexamethasone

Quick Link(s):

Regimen Monograph

Sep 2019

Regimen

EPIR(W)

Cancer Type:

Breast

Intent: Palliative

Drugs Used:

EPIrubicin

Quick Link(s):

Regimen Monograph

Aug 2019

Regimen

ETOP(PO)

Cancer Type:

Central Nervous System

Intent: Palliative

Funding:

ODB - General Benefit

etoposide - oral capsules

Drugs Used:

etoposide